Drug Topics

JULY 18, 2024

House Bill (HB) 1993 seeks to increase PBM transparency and accountability in an effort to combat the rising cost of prescription drugs.

236

236

Pharmacy Times

JULY 18, 2024

A large portion of the population of patients in the United States with GERD have the non-erosive type of the disease.

FDA 160

FDA 160

Drug Topics

JULY 18, 2024

Mayank Amin, PharmD, RPh, MBA, sat down with Drug Topics on part 1 of an episode of Over the Counter to share his experiences transforming a shuttered independent pharmacy into a thriving community hub.

Community Pharmacies 227

Community Pharmacies Independent Pharmacies 227

Pharmacy Times

JULY 18, 2024

The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.

153

153

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JULY 18, 2024

The sprawling enterprise that is UnitedHealth Group is undergoing more layoffs under its Optum umbrella. | UnitedHealth's Optum is again laying off workers, with the scope unconfirmed. Landmark Health is downsizing once again and leaving major metropolitan areas.

141

141

Pharmacy Times

JULY 18, 2024

Acetylcholine deficit observed in patients with anorexia nervosa suggest potential targeted treatment options.

144

144

Pharmacy Times

JULY 18, 2024

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

139

139

STAT

JULY 18, 2024

The Broad Institute of MIT and Harvard is perhaps best known for the trailblazing work coming out of the labs of its core members; CRISPR tools like David Liu’s prime and base editors , Feng Zhang’s virus-like drug delivery particles , or Pardis Sabeti’s network of low-cost diagnostics designed to catch the next pandemic before it starts.

138

138

Fierce Healthcare

JULY 18, 2024

A new nationwide scorecard ranks the state of women’s health and reproductive care. The results reveal a deep geographic divide in women’s healthcare access and outcomes. | The state-by-state rankings found “significant” disparities between states and deepening racial and ethnic gaps in outcomes. The findings suggest these gaps could widen further, especially for women of color and those with low incomes in states with restricted access to reproductive care.

131

131

STAT

JULY 18, 2024

WASHINGTON – A new study published Thursday finds that several mushroom candies, which are widely promoted as containing legal psychedelic ingredients, actually contain illegal hallucinogens. The study sampled products sold in gas stations and smoke shops near Charlottesville, Va. It identified the Schedule I drug psilocin in mushroom candies sold under the brand names Diamond Shruumz and Wonderland Legal Psychedelics.

Compounding 138

Compounding FDA 138

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

JULY 18, 2024

Pfizer’s blockbuster drug tafamidis for the treatment of the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM) needs at least a 96% discount off its list price to be considered cost | Pfizer’s blockbuster tafamidis for the treatment of the rare heart disease ATTR-CM needs at least a 96% discount off its list price to be considered cost-effective under common benchmarks, a draft report by ICER has found.

128

128

STAT

JULY 18, 2024

An expansive new study offers clear evidence that sequencing the genomes of diverse populations can yield fresh insights into how our DNA shapes our health. A team of researchers involved in an ongoing project spearheaded by the U.S. Department of Veterans Affairs analyzed data from nearly 636,000 veterans to look for genetic variants associated with more than 2,000 traits, such as height, blood glucose levels, and whether subjects had certain cancers.

Department of Veterans Affairs 138

Department of Veterans Affairs 138

Fierce Healthcare

JULY 18, 2024

Intermountain Health and NeuroFlow have teamed up to bring behavioral health screening and analytics to primary care patients in Colorado. | NeuroFlow will integrate behavioral health analytics into care workflows and engage patients with relevant digital resources and interventions. It will also provide suicide prevention services to patients and offer outreach from trained crisis professionals.

126

126

STAT

JULY 18, 2024

A prevention-focused co-founded by the head of a Stanford research lab is making an expensive bet with its latest fundraise: that it can build a better full-body scanner than medical device behemoths selling MRIs to health systems. Palo Alto-based Q Bio raised $27 million in “strategic funding” from existing investors including Khosla Ventures, Andreessen Horowitz, and Founders Fund, the company shared with STAT exclusively.

135

135

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JULY 18, 2024

GoodRx is joining forces with drugmaker Boehringer Ingelheim to make its Humira biosimilar adalimumab available at an affordable price. | GoodRx is joining forces with drugmaker Boehringer Ingelheim to make its Humira biosimilar adalimumab available at an affordable price.

125

125

Pharmacy Times

JULY 18, 2024

The SPN team's key focus was collaborating with the sports medicine community and discussing ways Sports Pharmacy can support athletic trainers in creating comprehensive care for athletes.

123

123

Fierce Healthcare

JULY 18, 2024

The hospital industry is warning that a proposed mandatory model for kidney transplants could introduce “unnecessary disruption and uncertainty to the transplant ecosystem” and ultimately undercut | Hospital lobbyists wrote that the Increasing Organ Transplant Access (IOTA) Model "is not fully developed and contains fundamental flaws” that would lead to a “potential negative impact on patient outcomes.

Hospitals 122

Hospitals 122

Pharmacy Times

JULY 18, 2024

The Pharmacy Quality Alliance Annual Meeting highlighted social determinants of health, oral oncolytics, and screening opportunities.

122

122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JULY 18, 2024

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next week, amid scrutiny of the sector's role in rising healthcare costs in the US.The hearing – scheduled for 23rd July – is part of an ongoing investigation by the committee into PBMs' alleged anticompetitive practices launched last year and spearheaded by chairman James Comer (R-Ky).

119

119

Pharmacy Times

JULY 18, 2024

IMROZ study data show Isa-VRd may be a new standard of care.

120

120

Fierce Pharma

JULY 18, 2024

As biopharma companies and the U.S. | As biopharma companies and the U.S. government near the deadline of their drug price talks under the Inflation Reduction Act, Novartis CEO said the cost cuts “might be manageable” in the short term for the firm’s first few products to be included.

118

118

STAT

JULY 18, 2024

If data represents the next gold rush for health care, a vast treasure trove of it slips away every day. The increased enthusiasm for AI has led to significant investments in novel solutions for health care, with data coming from a variety of sources such as medical charts, imaging, literature, guidelines, and the like. A largely untapped source of valuable data is staring health care practitioners like myself right in the face: monitors that track vital signs.

Patient Care 116

Patient Care Hospitals 116

pharmaphorum

JULY 18, 2024

J&J has three of its top-selling drugs in Medicare pricing negotiations but does not expect a major hit to its finances next year

116

116

Drug Topics

JULY 18, 2024

The drug was FDA approved as antihemophilic factor (recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (Altuviiio) in February 2023.

FDA 112

FDA 112

pharmaphorum

JULY 18, 2024

Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with fibrosing lung diseases

115

115

Drug Topics

JULY 18, 2024

All participants in the phase 3 clinical trial have completed their primary vaccination series.

Vaccines 112

Vaccines 112

pharmaphorum

JULY 18, 2024

While clinical development rates are falling, there is still hope in the Phase I bio sector. Learn more about the potential opportunities and positives in this challenging trend.

111

111

Drug Topics

JULY 18, 2024

In part 2 of the latest episode of Over the Counter, Mayank Amin, PharmD, RPh, MBA, discusses his journey as the Superman Pharmacist and expresses hope for the future of community pharmacy.

Community Pharmacies 112

Community Pharmacies 112

pharmaphorum

JULY 18, 2024

Ursula von der Leyen highlights biotech and AI as key sectors in speech as she is re-elected as President of the European Commission

111

111

Drug Topics

JULY 18, 2024

Patients using isCGM had reduced glucose variability, time in low glucose range, time in very low glucose range, and less events related to low glucose levels.

112

112

Pharmaceutical Technology

JULY 18, 2024

The new hub will act as a central point of connection and engagement for the rare disease community for FDA-related concerns.

FDA 111

FDA 111

Drug Topics

JULY 18, 2024

The approval offers a first of its kind treatment option for patients living with nonerosive GERD.

FDA 112

FDA 112

STAT

JULY 18, 2024

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Hello! It’s so damn hot. Apologies for the delay in delivery this morning, but I wanted to include a Novartis-pelabresib update from its earnings announcement. It’s the lead item below.

110

110